29 January – Monday

08:30 Registration
08:45 Opening Remarks and Welcome Address
09:00 SESSION: IO & PRACTICE GUIDELINES
Moderators: Antonio Gasbarrini – Nahum Goldberg

  • Single HCC < 3cm: RFA or MWA?
    RFA                                          Maurizio Pompili
    MWA                                       Okhan Akhan
    Discussant/Summing up: Andrea Veltri
  • Single HCC > 3 cm: MWA or Combined Treatment?
    MWA                                       Mario Bezzi
    Combined Treatment         Laura Crocetti
    Discussant/Summing up: Francesco Grasso
  • Multinodular HCC/Intermediate Stage: TACE or TARE?
    TACE                                       Katerina Malagari
    TARE                                       Ignacio Josè Bilbao
    Discussant/Summing up: Ehran Ilgit
  • HCC & PVT: Medical Therapy or TARE?
    Medical Therapy                 Mustapha Benazzouz
    TARE                                       Irene Bargellini
    Discussant/Summing up: Mohamed Hosni
10:30 EXPERT PANEL DISCUSSION: Early Stage HCC
INTERACTIVE MULTIDISCIPLINARY TREATMENT DECISION

Moderator: R. Iezzi
PANELISTS: Hicham Abada, Salvatore Agnes, Okan Akhan, Antonio Ascione, Laura Crocetti, Antonio Gasbarrini, Felice Giuliante, Nahum Goldberg, Maurizio Pompili, Vladimir Dimov
11:10 The “7 DEADLY SINS & 7 VIRTUES”: Percutaneous Devices
Dimitrios Filippiadis
11:30 Coffee Break
11:45 LIVE CASES (Treatment Strategies based on “Expert Panel Discussion”)
12:15 HONORARY LECTURE: New antiviral treatment for HCV: does it wake up sleepy malignant cells?
Massimo G. Colombo
12:40 BE INNOVATIVE, SHARE YOUR EXPERIENCE
Moderator: Michele Rossi – Najjar Taoufik
Oral Communication: Preclinical Data
4 ABSTRACTS (5+2 x4: 30min)
13:00 LIVE CASES (Treatment Strategies based on “Expert Panel Discussion”)
13:30 LUNCH SYMPOSIUM
14:30 HONORARY LECTURE: Biomarkers and Imaging findings to predict Interventional Oncology response
Nahum Goldberg
15:15 SESSION: IO & Technological-Economical Issues
Moderators: Ahmed Sami – Alberto Montori

Live Cases (Treatment Strategies based on “Expert Panel Discussion”)

  • Planning & Guidance Software for percutaneous hepatic treatments
    Hicham Abada
  • Laparoscopic Ablation for liver lesions: when and why?
    Umberto Cillo
  • Trans-radial Intra-arterial Approach for Hepatic Treatments: how, when, and why?
    Roberto Iezzi
  • Radiation Oncology for liver disease: where are we going?
    Giancarlo Mattiucci
  • Economical Sustainability: is IO worth the investment?
    Americo Cicchetti

Discussants: Eleonora Annicchiarico, Maurizio Cariati, Antonio Raffaele Cotroneo, Carlo Fugazzola, Antonio Orlacchio, Nabil Debzi

16:45 Coffee Break
17:00 EXPERT PANEL DISCUSSION: Intermediate-Stage HCC
INTERACTIVE MULTIDISCIPLINARY TREATMENT DECISION
MODERATOR: Maurizio Pompili
PANELISTS: Francesco Ardito, Antonello Basile, Josè Ignacio Bilbao, Antonio Grieco, Katerina Malagari, GianLodovico Rapaccini, Massimo Siciliano, Massimo Venturini, Nabil Debzi
17:40 The “7 DEADLY SINS & 7 VIRTUES”: Catheter/Microcatheter
Maurizio Grosso
18:15 Plenary Discussion on patients treated

 

30 January – Tuesday

08:30 SESSION: IO & Evidence-Based Practice
Moderators: Carlo Barone – Felice Giuliante
Live Cases (Treatment Strategies based on “Expert Panel Discussion”)

  • mCRC & Medical Treatments: where are we going?
    Alessandra Cassano
  • mCRC & Percutaneous Options: what’s new?
    Franca Meloni
  • mCRC & Intra-arterial Options: which evidences?
    Irene Bargellini
  • Question Time: oncologist point of view
    Carmelo Pozzo
10:00 EXPERT PANEL DISCUSSION: Advanced-Stage HCC
INTERACTIVE MULTIDISCIPLINARY TREATMENT DECISION
MODERATOR: Riccardo Manfredi
PANELISTS: Alfonso Avolio, Irene Bargellini Mustapha Benazzouz, Roberto Cianni, Giammaria Fiorentini, Mohamed Hamed, Jens Ricke, Carlo Spreafico, Hugo Rio Tinto, Maurizio Cosimelli
10:30 LIVE CASES (Treatment Strategies based on “Expert Panel Discussion”)
11:00 Coffee Break
11:20 HONORARY LECTURE: IMMUNOTHERAPY & LOCOREGIONAL TREATMENTS
Gosse Adema (Belgium)
11:40 LIVE CASES (Treatment Strategies based on “Expert Panel Discussion”)
12:00 The “7 DEADLY SINS & 7 VIRTUES”: Embolic Agents (15 mins)
Jens Ricke
12:15 BE INNOVATIVE, SHARE YOUR EXPERIENCE
Moderators: Peter Popovic
ORAL COMMUNICATION: New Devices/Techniques
4 ABSTRACTS (5+2 x4: 30min)
13:00 HONORARY LECTURE: The emergent role of Radioembolization: Present and Future Prospectives
Ignacio Josè Bilbao
13:30 LUNCH
14:30 HONORARY LECTURE: Contribution of the Mediterranean Task force for Cancer Control in the fight against cancer
Pier Giorgio Natali
15:00 SESSION: IO & Pancreatic Tumors
Moderators: Giampaolo Tortora – Riccardo Manfredi
Live Cases (Treatment Strategies based on “Expert Panel Discussion”)

  • Medical Treatments: where are we going?
    Davide Melisi
  • Surgical Option: when is it unresectable?
    Sergio Alfieri
  • Endoscopic Approach: current and future prospectives
    Guido Costamagna
  • Radiation Oncology: current and future prospectives
    Vincenzo Valentini
  • Interventional Oncology: current and future prospectives
    Giampaolo Carrafiello
  • Interventional Oncology: which role for IRE?
    Martijn Meijerink

Discussants: Alessandro Cina, Roberto Cioni, Carmine Di Stasi, Domenico D’Ugo, Guido Rindi, Giovanni Schinzari

17:00 BE INNOVATIVE, SHARE YOUR EXPERIENCE
Moderator: Hugo Rio Tinto – Abdel Naser El Zouki
ORAL COMMUNICATION: (Morbidity/Mortality)
17:30 LIVE CASES (Treatment Strategies based on “Expert Panel Discussion”)
18:00 Plenary Discussion on patients treated
18:15 End